Valuation: Farmacias Benavides, S.A.B. de C.V.

Market Cap 10.22B 585M 514M 478M 439M 824M 56.38B 837M 5.68B 2.22B 27.72B 2.2B 2.15B 95.83B P/E 2024
68.9x
P/E 2025 47.4x
Enterprise Value 11.96B 685M 601M 559M 513M 964M 65.95B 979M 6.64B 2.59B 32.42B 2.57B 2.52B 112B EV / Sales 2024
0.69x
EV / Sales 2025 0.64x
Free-Float
16.07%
Yield 2024 *
-
Yield 2025 -
05-26 Mexico's Farmacias Benavides starts process to delist from official securities registry RE
04-30 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-26 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
25-10-28 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-07-28 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-04-29 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-02-26 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
24-08-15 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-13 Farmacias Benavides, S.A.B. de C.V. Auditor Raises 'Going Concern' Doubt CI
24-04-25 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-02-26 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
23-10-27 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
23-07-28 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Manager TitleAgeSince
Chief Executive Officer - 2024-12-01
Director of Finance/CFO - 2026-03-16
Director of Finance/CFO - -
Director TitleAgeSince
Chairman - 2023-05-01
Director/Board Member - 2020-12-31
Director/Board Member - 2023-05-01
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 583M
+1.52%+2.04%+5.45%+12.25% 6.54B
+0.83%-0.60%-20.92%+39.16% 3.18B
+0.53%-1.13%-31.93%-20.38% 3B
+0.03%-1.05%-17.34%-8.08% 2.69B
+0.38%-2.90%-6.18%+39.85% 2.15B
-3.00%-4.24%-37.23%-43.44% 1.38B
+0.91%-0.60%-3.19%-4.03% 1.3B
+0.76%-1.62%+17.60%+53.62% 451M
+2.04%+2.17%-42.65%-68.13% 364M
Average +0.40%-1.15%-15.16%+0.09% 2.34B
Weighted average by Cap. +0.61%-1.06%-11.86%+6.71%

Financials

2024 2025
Net sales 17.65B 1.01B 888M 826M 758M 1.42B 97.33B 1.45B 9.8B 3.83B 47.85B 3.79B 3.71B 165B 19.46B 1.11B 979M 910M 835M 1.57B 107B 1.59B 10.81B 4.22B 52.77B 4.18B 4.09B 182B
Net income 131M 7.48M 6.57M 6.11M 5.6M 10.53M 720M 10.69M 72.51M 28.33M 354M 28.06M 27.46M 1.22B 224M 12.84M 11.27M 10.48M 9.62M 18.08M 1.24B 18.36M 124M 48.64M 608M 48.19M 47.15M 2.1B
Net Debt 3.26B 187M 164M 152M 140M 263M 17.98B 267M 1.81B 707M 8.84B 701M 686M 30.56B 1.73B 99.35M 87.26M 81.15M 74.47M 140M 9.57B 142M 964M 376M 4.7B 373M 365M 16.26B
Logo Farmacias Benavides, S.A.B. de C.V.
Farmacias Benavides SAB de CV is a Mexico-based company primarily engaged in the pharmaceutical and chemical industry. The Company operates a network of over 700 drug stores located nationwide under the Farmacias Benavides name. Through its network of drug stores, it sells a variety prescription and over the counter (OTC) medicines, cosmetics, personal and baby care products and toiletries, as well as it also provides such related services as laboratory samples, home delivery, prescription laboratory, online pharmacy and photo processing services. As of December 31, 2011, the Company owned such subsidiaries as Servicios Operacionales Benavides SA de CV, Benavides de Reynosa SA de CV and Servicios Logisticos Benavides SA de CV, and Fasa Investment Limitada which was its majority shareholder with 85.25% of its interest.
Employees
-